SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-18-000101
Filing Date
2018-09-05
Accepted
2018-09-04 21:39:43
Documents
6
Period of Report
2018-08-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim8k.htm 8-K 39011
2 EXHIBIT 3.1 exhibit31.htm EX-3.1 136456
3 EXHIBIT 3.2 exhibit32.htm EX-3.2 12054
4 EXHIBIT 10.1 exhibit101.htm EX-10.1 111674
5 EXHIBIT 99.1 exhibit991.htm EX-99.1 15467
6 exhibit991image1a02.jpg GRAPHIC 23407
  Complete submission text file 0001267602-18-000101.txt   348459
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 6789905740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 181053778
SIC: 2834 Pharmaceutical Preparations